|
|
Ross McLeod joins World Health Organization Technical and Scientific Advisory Group on the Development of Target Product Profiles (TPPs) for Snake Antivenom Products |
|
WHO is targeting a 50% reduction in deaths and disabilities caused by snakebite envenoming (snakebite) by 2030. To achieve this, access to safe, effective, and affordable antivenom in snakebite endemic countries, particularly in Sub-Saharan Africa, is critical. WHO is exploring a pathway for prequalification of antivenoms and identified a need to develop Target Product Profiles (TPPs) to support optimization of current and emerging products. WHO, in close collaboration with DNDi, will work on the development of TPPs for snake antivenom products for Sub-Saharan Africa and other snakebite endemic regions. Resulting TPPs will assist product standardization and guide more targeted research and development of antivenoms across the world
https://www.who.int/news-room/articles-detail/technical-and-scientific-advisory-group-on-the-development-of-target-product-profiles-for-snake-antivenom-products
|
|